349 related articles for article (PubMed ID: 23867625)
21. 1α,25-Dihydroxyvitamin D
Xiong Y; Zhang Y; Xin N; Yuan Y; Zhang Q; Gong P; Wu Y
J Steroid Biochem Mol Biol; 2017 Nov; 174():153-160. PubMed ID: 28859991
[TBL] [Abstract][Full Text] [Related]
22. FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts.
Rached MT; Kode A; Xu L; Yoshikawa Y; Paik JH; Depinho RA; Kousteni S
Cell Metab; 2010 Feb; 11(2):147-60. PubMed ID: 20142102
[TBL] [Abstract][Full Text] [Related]
23. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
[TBL] [Abstract][Full Text] [Related]
24. Forkhead box O transcription factors in chondrocytes regulate endochondral bone formation.
Eelen G; Verlinden L; Maes C; Beullens I; Gysemans C; Paik JH; DePinho RA; Bouillon R; Carmeliet G; Verstuyf A
J Steroid Biochem Mol Biol; 2016 Nov; 164():337-343. PubMed ID: 26232637
[TBL] [Abstract][Full Text] [Related]
25. Runx1 regulates osteogenic differentiation of BMSCs by inhibiting adipogenesis through Wnt/β-catenin pathway.
Luo Y; Zhang Y; Miao G; Zhang Y; Liu Y; Huang Y
Arch Oral Biol; 2019 Jan; 97():176-184. PubMed ID: 30391794
[TBL] [Abstract][Full Text] [Related]
26. Bcl2 deficiency activates FoxO through Akt inactivation and accelerates osteoblast differentiation.
Moriishi T; Kawai Y; Komori H; Rokutanda S; Eguchi Y; Tsujimoto Y; Asahina I; Komori T
PLoS One; 2014; 9(1):e86629. PubMed ID: 24466179
[TBL] [Abstract][Full Text] [Related]
27. Deletion of FoxO1, 3, and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes.
Iyer S; Han L; Ambrogini E; Yavropoulou M; Fowlkes J; Manolagas SC; Almeida M
J Bone Miner Res; 2017 Jan; 32(1):60-69. PubMed ID: 27491024
[TBL] [Abstract][Full Text] [Related]
28. Sirtuin1 Suppresses Osteoclastogenesis by Deacetylating FoxOs.
Kim HN; Han L; Iyer S; de Cabo R; Zhao H; O'Brien CA; Manolagas SC; Almeida M
Mol Endocrinol; 2015 Oct; 29(10):1498-509. PubMed ID: 26287518
[TBL] [Abstract][Full Text] [Related]
29. Postnatal ablation of osteoblast Smad4 enhances proliferative responses to canonical Wnt signaling through interactions with β-catenin.
Salazar VS; Zarkadis N; Huang L; Watkins M; Kading J; Bonar S; Norris J; Mbalaviele G; Civitelli R
J Cell Sci; 2013 Dec; 126(Pt 24):5598-609. PubMed ID: 24101723
[TBL] [Abstract][Full Text] [Related]
30. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors.
Evans-Anderson HJ; Alfieri CM; Yutzey KE
Circ Res; 2008 Mar; 102(6):686-94. PubMed ID: 18218983
[TBL] [Abstract][Full Text] [Related]
31. Wnt/β-catenin pathway regulates bone morphogenetic protein (BMP2)-mediated differentiation of dental follicle cells.
Silvério KG; Davidson KC; James RG; Adams AM; Foster BL; Nociti FH; Somerman MJ; Moon RT
J Periodontal Res; 2012 Jun; 47(3):309-19. PubMed ID: 22150562
[TBL] [Abstract][Full Text] [Related]
32. Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma.
Kang S; Bennett CN; Gerin I; Rapp LA; Hankenson KD; Macdougald OA
J Biol Chem; 2007 May; 282(19):14515-24. PubMed ID: 17351296
[TBL] [Abstract][Full Text] [Related]
33. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
Dieudonné FX; Marion A; Marie PJ; Modrowski D
J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
[TBL] [Abstract][Full Text] [Related]
34. Enhanced anticancer synergy of LOM612 in combination with selinexor: FOXO1 nuclear translocation-mediated inhibition of Wnt/β-catenin signaling pathway in breast cancer.
Xu S; Shi Y; Li S
Cancer Chemother Pharmacol; 2024 Mar; 93(3):191-202. PubMed ID: 38051377
[TBL] [Abstract][Full Text] [Related]
35. Unraveling the role of FoxOs in bone--insights from mouse models.
Almeida M
Bone; 2011 Sep; 49(3):319-27. PubMed ID: 21664311
[TBL] [Abstract][Full Text] [Related]
36. Gsα enhances commitment of mesenchymal progenitors to the osteoblast lineage but restrains osteoblast differentiation in mice.
Wu JY; Aarnisalo P; Bastepe M; Sinha P; Fulzele K; Selig MK; Chen M; Poulton IJ; Purton LE; Sims NA; Weinstein LS; Kronenberg HM
J Clin Invest; 2011 Sep; 121(9):3492-504. PubMed ID: 21804192
[TBL] [Abstract][Full Text] [Related]
37. Tanshinol alleviates impaired bone formation by inhibiting adipogenesis via KLF15/PPARγ2 signaling in GIO rats.
Yang YJ; Zhu Z; Wang DT; Zhang XL; Liu YY; Lai WX; Mo YL; Li J; Liang YL; Hu ZQ; Yu YJ; Cui L
Acta Pharmacol Sin; 2018 Apr; 39(4):633-641. PubMed ID: 29323335
[TBL] [Abstract][Full Text] [Related]
38. Fermented Oyster Extract Promotes Osteoblast Differentiation by Activating the Wnt/β-Catenin Signaling Pathway, Leading to Bone Formation.
Molagoda IMN; Karunarathne WAHM; Choi YH; Park EK; Jeon YJ; Lee BJ; Kang CH; Kim GY
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31698882
[TBL] [Abstract][Full Text] [Related]
39. Integrin-Linked Kinase Regulates Bone Formation by Controlling Cytoskeletal Organization and Modulating BMP and Wnt Signaling in Osteoprogenitors.
Dejaeger M; Böhm AM; Dirckx N; Devriese J; Nefyodova E; Cardoen R; St-Arnaud R; Tournoy J; Luyten FP; Maes C
J Bone Miner Res; 2017 Oct; 32(10):2087-2102. PubMed ID: 28574598
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix.
Zhang C; Cho K; Huang Y; Lyons JP; Zhou X; Sinha K; McCrea PD; de Crombrugghe B
Proc Natl Acad Sci U S A; 2008 May; 105(19):6936-41. PubMed ID: 18458345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
